These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22432515)

  • 1. Physicochemical characterization of creatine N-methylguanidinium salts.
    Gufford BT; Sriraghavan K; Miller NJ; Miller DW; Gu X; Vennerstrom JL; Robinson DH
    J Diet Suppl; 2010 Sep; 7(3):240-52. PubMed ID: 22432515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the combined approach of N-alkylation and salt formation to enhance aqueous solubility of tertiary amines using bupivacaine as a model drug.
    Nielsen AB; Frydenvang K; Liljefors T; Buur A; Larsen C
    Eur J Pharm Sci; 2005 Jan; 24(1):85-93. PubMed ID: 15626581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salt and cocrystals of sildenafil with dicarboxylic acids: solubility and pharmacokinetic advantage of the glutarate salt.
    Sanphui P; Tothadi S; Ganguly S; Desiraju GR
    Mol Pharm; 2013 Dec; 10(12):4687-97. PubMed ID: 24168322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of counterions on physicochemical properties of prazosin salts.
    Kumar L; Meena CL; Pawar YB; Wahlang B; Tikoo K; Jain R; Bansal AK
    AAPS PharmSciTech; 2013 Mar; 14(1):141-50. PubMed ID: 23250707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the counterion on the solubility and physicochemical properties of salts of carboxylic acid drugs.
    David SE; Timmins P; Conway BR
    Drug Dev Ind Pharm; 2012 Jan; 38(1):93-103. PubMed ID: 22118222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamivudine salts with improved solubilities.
    Martins FT; Bonfilio R; De Araújo MB; Ellena J
    J Pharm Sci; 2012 Jun; 101(6):2143-54. PubMed ID: 22419054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aqueous solubility, effects of salts on aqueous solubility, and partitioning behavior of hexafluorobenzene: experimental results and COSMO-RS predictions.
    Schröder B; Freire MG; Varanda FR; Marrucho IM; Santos LM; Coutinho JA
    Chemosphere; 2011 Jul; 84(4):415-22. PubMed ID: 21507458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional hydrogen-bonded structures in the guanidinium salts of the monocyclic dicarboxylic acids rac-trans-cyclohexane-1,2-dicarboxylic acid (2:1, anhydrous), isophthalic acid (1:1, monohydrate) and terephthalic acid (2:1, trihydrate).
    Smith G; Wermuth UD
    Acta Crystallogr C; 2010 Dec; 66(Pt 12):o575-80. PubMed ID: 21123887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of pharmaceutical salts and cocrystals to address the issue of poor solubility.
    Elder DP; Holm R; Diego HL
    Int J Pharm; 2013 Aug; 453(1):88-100. PubMed ID: 23182973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of solubility and dissolution of a free base and two different salt forms as a function of pH.
    Li S; Wong S; Sethia S; Almoazen H; Joshi YM; Serajuddin AT
    Pharm Res; 2005 Apr; 22(4):628-35. PubMed ID: 15846471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diflunisal salts of bupivacaine, lidocaine and morphine. Use of the common ion effect for prolonging the release of bupivacaine from mixed salt suspensions in an in vitro dialysis model.
    Larsen SW; Østergaard J; Poulsen SV; Schulz B; Larsen C
    Eur J Pharm Sci; 2007 Jul; 31(3-4):172-9. PubMed ID: 17462869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the stability of creatine in solution prepared from effervescent creatine formulations.
    Ganguly S; Jayappa S; Dash AK
    AAPS PharmSciTech; 2003; 4(2):E25. PubMed ID: 12916907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine increases the solubility of coumarin: comparison with salting-in and salting-out additives.
    Hirano A; Arakawa T; Shiraki K
    J Biochem; 2008 Sep; 144(3):363-9. PubMed ID: 18583357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bupivacaine salts of diflunisal and other aromatic hydroxycarboxylic acids: aqueous solubility and release characteristics from solutions and suspensions using a rotating dialysis cell model.
    Østergaard J; Larsen SW; Parshad H; Larsen C
    Eur J Pharm Sci; 2005 Nov; 26(3-4):280-7. PubMed ID: 16087321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interactions of unconjugated bilirubin with bile acid by rapid solvent partition].
    Hahm JS; Mun GH; Lee HL; Eun CS; Park JY; Han DS; Choi HS; Ahn YH
    Taehan Kan Hakhoe Chi; 2002 Mar; 8(1):80-9. PubMed ID: 12499820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal absorption of calcium from milk and calcium salts.
    Sheikh MS; Santa Ana CA; Nicar MJ; Schiller LR; Fordtran JS
    N Engl J Med; 1987 Aug; 317(9):532-6. PubMed ID: 3614304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the aqueous solubility of triclosan by solubilization, complexation, and in situ salt formation.
    Grove C; Liebenberg W; du Preez JL; Yang W; de Villiers MM
    J Cosmet Sci; 2003; 54(6):537-50. PubMed ID: 14730370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ salt screening--a useful technique for discovery support and preformulation studies.
    Tong WQ; Whitesell G
    Pharm Dev Technol; 1998 May; 3(2):215-23. PubMed ID: 9653759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salt formation to improve drug solubility.
    Serajuddin AT
    Adv Drug Deliv Rev; 2007 Jul; 59(7):603-16. PubMed ID: 17619064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precaution on use of hydrochloride salts in pharmaceutical formulation.
    Miyazaki S; Oshiba M; Nadai T
    J Pharm Sci; 1981 Jun; 70(6):594-6. PubMed ID: 7252797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.